by xplorelab | Nov 14, 2024 | Awards
The federal government announced a new round of Canada Research Chairs in November 2024, including three based at The Ottawa Hospital. Dr. Bernard Thébaud, neonatologist and senior scientist in OHRI’s Regenerative Medicine Program, was appointed Tier 1 Canada...
by xplorelab | Sep 16, 2024 | Funding
Dr. Bernard Thébaud was awarded $2.8 million from the Canadian Institutes of Health Research Clinical Trials Fund for a Phase 2 clinical trial using mesenchymal stromal cells (MSCs) to treat bronchopulmonary dysplasia (BPD) in premature babies. Very premature babies...
by xplorelab | Jul 3, 2024 | Awards
Congratulations to Mahnaz on the receipt of the 2024 Bell Family Pediatric PH Research Scholarship awarded by PHA Canada! You can read more about her award here: https://phacanada.ca/Research/Research-Scholarships
by xplorelab | Mar 29, 2023 | Ottawa Hospital Research Institute, Research, The Ottawa Hospital
Dr. Thébaud’s team has treated the first patient in an innovative cell therapy clinical trial – the first of its kind in the world – that aims to prevent very premature babies from developing a chronic lung disease called bronchopulmonary dysplasia (BPD)....
by xplorelab | Sep 22, 2022 | Ottawa Hospital Research Institute, Research, The Ottawa Hospital
A new publication uncovers clues as to why preterm babies with bronchopulmonary dysplasia (BPD) may have problems learning, thinking and remembering. A study led by former Xplore Lab team member Dr. Marissa Lithopoulos found that extra oxygen damaged the structure and...
